Table 4.
Axis I diagnoses for Phase Three participants (n = 48)
| Principal diagnosis: CSR ≥ 4 | Secondary diagnosis: CSR > 0 | Total in sample: CSR > 0 | |
|---|---|---|---|
| SAD | 32 (70%) | 7 (15%) | 39 (85%) |
| SPa | 1 (2%) | 11 (24%) | 12 (26%) |
| AG | 0 (0%) | 14 (30%) | 14 (30%) |
| PD | 5 (10%) | 9 (20%) | 14 (30%) |
| GAD | 8 (17%) | 9 (20%) | 17 (37%) |
| OCD | 2 (4%) | 1 (2%) | 3 (6%) |
| PTSD | 0 (0%) | 3 (6%) | 3 (6%) |
| MDD | 0 (0%) | 14 (30%) | 14 (30%) |
| DD | 0 (0%) | 7 (15%) | 7 (15%) |
Note: Principal and secondary diagnoses determined by Anxiety Disorders Interview Schedule for DSM‐IV (ADIS‐IV). Clinical Severity Ratings (CSRs) ranged from 0–8. SAD, Social Anxiety Disorder; SP, Specific Phobia; AG, Agoraphobia; PD, Panic Disorder; GAD, Generalized Anxiety Disorder; OCD, Obsessive Compulsive Disorder; PTSD, Posttraumatic Stress Disorder; MDD, Major Depressive Disorder; DD, Dysthymic Disorder.
Specifiers for individuals diagnosed with Specific Phobia: Situational = 8 (17%), Animal = 2 (4%), Blood Injection Injury = 2 (4%), Natural Environment = 1 (2%), Other = 3 (6%). There are a total of 16 specifiers for 12 individuals due to the fact that four of the individuals diagnosed with specific phobia met criteria for two specifiers.